SynthesisJournal of diabetes investigation2026
Association between stress hyperglycemia ratio and prognosis of patients hospitalized with COVID-19: A meta-analysis.
Synthesis in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AIMS/
introductionStress hyperglycemia ratio (SHR), calculated by dividing admission glucose levels by estimated chronic glucose levels, has emerged as a novel marker of glycemic stress. However, its prognostic value in patients hospitalized with COVID-19 remains unclear. This meta-analysis investigates the association between SHR and adverse outcomes in this population. MATERIALS AND
methodsA comprehensive literature search was conducted in PubMed, Embase, and Web of Science databases for relevant observational studies. The primary outcome was a composite of ICU admission, invasive mechanical ventilation (IMV), and all-cause in-hospital mortality. Secondary outcomes included the individual components of the primary outcome. A random effects model was used to pool the results by incorporating heterogeneity.
resultsSeven studies involving 2,272 patients were included. Patients with a high SHR had a significantly higher risk of poor composite outcomes (risk ratio [RR]: 1.93, 95% confidence interval [CI]: 1.54-2.43; I
conclusionsHigh SHR at admission is independently associated with poor prognosis in patients hospitalized with COVID-19. However, as admission glucose levels in most studies were not standardized for fasting status, SHR may be influenced by postprandial hyperglycemia, which should be considered when interpreting its prognostic value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.